You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stage III melanoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Stage III Trial in Shanghai (Toripalimab combined with Temozolomide)

Not yet recruiting
  • Melanoma Stage III
  • Toripalimab combined with Temozolomide
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 23, 2023

Melanoma Stage III Trial in North Sydney (Pembrolizumab, Lenvatinib)

Recruiting
  • Melanoma Stage III
  • North Sydney, New South Wales, Australia
    Melanoma Institute Australia
Oct 26, 2022

Melanoma, Complication Trial in Oslo (Suction drain)

Completed
  • Melanoma
  • Complication
  • Suction drain
  • Oslo, Norway
    Oslo University Hospital
Sep 1, 2022

Conservative Nodal Surgery of Stage III Melanoma With Low-burden

Recruiting
  • Melanoma Stage III
    • Seville, Spain
      Dermatology Department. University Hospital Virgen Macarena
    Jun 30, 2022

    Clinical Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +5 more
    • Jacksonville, Florida
    • +2 more
    Oct 21, 2022

    Improve Early Detection of Cancer Recurrence in High-Risk

    Recruiting
    • Stage III Melanoma
    • Stage IV Cutaneous Melanoma
      • Cleveland, Ohio
        Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
      Oct 6, 2022

      Melanoma Trial (pembrolizumab, )

      Active, not recruiting
      Has Results
      • Melanoma
      • pembrolizumab
      • placebo
      • (no location specified)
      Aug 18, 2022

      Melanoma Trial in Charlottesville (Excision of clinically detected lymph node metastasis before any systemic therapy, Excision

      Not yet recruiting
      • Melanoma
      • Excision of clinically detected lymph node metastasis before any systemic therapy
      • Excision of clinically detected lymph node metastasis after neoadjuvant systemic therapy
      • Charlottesville, Virginia
        Cancer Center at the University of Virginia
      Apr 20, 2023

      Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Shanghai (Endostar,

      Recruiting
      • Clinical Stage III Cutaneous Melanoma AJCC v8
      • Clinical Stage IV Cutaneous Melanoma AJCC v8
      • Shanghai, China
        Fudan University Shanghai Cancer Center
      Jun 17, 2023

      Stage III Melanoma, Stage IV Melanoma Trial in Los Angeles, Denver (TBX-3400)

      Recruiting
      • Stage III Melanoma
      • Stage IV Melanoma
      • TBX-3400
      • Los Angeles, California
      • +1 more
      May 1, 2022

      Unresectable Melanoma, Metastatic Melanoma, Stage III Melanoma Trial in Boston (Sargramostim (GM-CSF), Pembrolizumab

      Recruiting
      • Unresectable Melanoma
      • +3 more
      • Sargramostim (GM-CSF)
      • Pembrolizumab (anti-PD-1)
      • Boston, Massachusetts
      • +1 more
      Jul 6, 2022

      Melanoma Trial (GME751, Keytruda - EU, Keytruda - US)

      Not yet recruiting
      • Melanoma
      • (no location specified)
      Nov 22, 2023

      Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Rochester (drug,

      Active, not recruiting
      • Metastatic Melanoma
      • +6 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 13, 2023

      Melanoma Stage IV, Melanoma Stage III, Immunetherapy Trial (nivolumab)

      Not yet recruiting
      • Melanoma Stage IV
      • +3 more
      • (no location specified)
      Dec 14, 2022

      Patients With Completely Resected High-risk Stage III Melanoma.

      Recruiting
      • Melanoma
      • Bursa, Gorukle, Turkey
      • +9 more
      Feb 28, 2022

      Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

      Recruiting
      • Melanoma Stage III
      • Melanoma Stage IV
      • San Francisco, California
        University of California, San Francisco
      Dec 6, 2022

      Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)

      Completed
      • Stage III Malignant Melanoma of Skin AJCC V6
      • Stage IV Malignant Melanoma of Skin
      • TAPCells vaccine
      • Santiago, RM, Chile
        Faculty of Medicine, University of Chile
      Nov 21, 2023

      Melanoma, Stage I, Melanoma, Stage II, Melanoma Stage III Trial (MSOT)

      Not yet recruiting
      • Melanoma, Stage I
      • +2 more
      • MSOT
      • (no location specified)
      Jul 15, 2022

      Melanoma Trial in Sydney, Wollstonecraft, Melbourne (Dabrafenib, Trametinib, Pembrolizumab)

      Active, not recruiting
      • Melanoma
      • Sydney, New South Wales, Australia
      • +2 more
      Apr 4, 2022

      Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

      Active, not recruiting
      • Stage III Cutaneous Melanoma AJCC v7
      • +4 more
      • Cryosurgery
      • +3 more
      • Rochester, Minnesota
        Mayo Clinic
      Jan 3, 2023

      Monitoring T Cell Responses in Melanoma, Lung and Other Cancer

      Recruiting
      • Clinical Stage III Cutaneous Melanoma AJCC v8
      • +9 more
      • Biospecimen Collection
      • Electronic Health Record Review
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Oct 4, 2023

      Melanoma Stage Iii, Melanoma Stage Iv, Melanoma Trial in Chapel Hill (Denosumab, Pembrolizumab, Nivolumab)

      Active, not recruiting
      • Melanoma Stage Iii
      • +4 more
      • Chapel Hill, North Carolina
        UNC Lineberger Comprehensive Cancer Center
      Jul 20, 2022

      Melanoma Stage III, Melanoma Stage IV, Inoperable Disease Trial in Tampa (Interleukin-2, Ipilimumab, Nivolumab)

      Recruiting
      • Melanoma Stage III
      • +2 more
      • Tampa, Florida
        Moffitt Cancer Center
      Dec 6, 2022

      Unresectable Melanoma, Metastatic Melanoma, Stage III NSCLC Trial in Louisville, New York (IOV-4001)

      Recruiting
      • Unresectable Melanoma
      • +3 more
      • IOV-4001
      • Louisville, Kentucky
      • +2 more
      Nov 21, 2022

      Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)

      Completed
      Has Results
      • Melanoma
      • Skin Cancer
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Jan 18, 2023